Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. Goschzik T, Mynarek M, Doerner E, Schenk A, et al. Acta Neuropathol 2022 Oct 1. pii: 10.1007/s00401-022-02505.

Read + Share

Amedeo Smart

Independent Medical Education

Goschzik T, Mynarek M, Doerner E, Schenk A, et al. Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. Acta Neuropathol 2022 Oct 1. pii: 10.1007/s00401-022-02505.
PMID: 36181537